ES2093257T3 - Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales. - Google Patents

Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales.

Info

Publication number
ES2093257T3
ES2093257T3 ES92909055T ES92909055T ES2093257T3 ES 2093257 T3 ES2093257 T3 ES 2093257T3 ES 92909055 T ES92909055 T ES 92909055T ES 92909055 T ES92909055 T ES 92909055T ES 2093257 T3 ES2093257 T3 ES 2093257T3
Authority
ES
Spain
Prior art keywords
torasemide
treatment
preparation
medicines intended
brain edemas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92909055T
Other languages
English (en)
Inventor
Tim Boelke
Lothar Kling
Reinhard Koenig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2093257T3 publication Critical patent/ES2093257T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UTILIZACION DE LA TORASEMIDA PARA EL TRATAMIENTO DE EDEMAS CEREBRALES Y TORASEMIDA DE ADMINISTRACION ORAL Y PARENTERAL.
ES92909055T 1991-04-27 1992-04-22 Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales. Expired - Lifetime ES2093257T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4113820A DE4113820A1 (de) 1991-04-27 1991-04-27 Verwendung von torasemid zur behandlung von hirnoedemen

Publications (1)

Publication Number Publication Date
ES2093257T3 true ES2093257T3 (es) 1996-12-16

Family

ID=6430498

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92909055T Expired - Lifetime ES2093257T3 (es) 1991-04-27 1992-04-22 Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales.

Country Status (8)

Country Link
EP (1) EP0583280B1 (es)
JP (1) JP3429507B2 (es)
AT (1) ATE141053T1 (es)
AU (1) AU1669092A (es)
CA (1) CA2108794C (es)
DE (2) DE4113820A1 (es)
ES (1) ES2093257T3 (es)
WO (1) WO1992019245A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008000737A1 (de) 2008-03-18 2009-09-24 Robert Bosch Gmbh Handwerkzeugmaschine, insbesondere handgeführte Schleifmaschine
US9241933B2 (en) 2011-03-01 2016-01-26 Pharnext Compositions for treating amyotrophic lateral sclerosis
US9867837B2 (en) 2011-03-01 2018-01-16 Pharnext Compositions for treating neurological disorders
UA113165C2 (xx) * 2011-03-01 2016-12-26 Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
US10010515B2 (en) 2011-03-01 2018-07-03 Pharnext Therapeutic approaches for treating Parkinson's disease
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
US9931326B2 (en) 2011-03-29 2018-04-03 Pharnext Composition comprising torasemide and baclofen for treating neurological disorders
CA2872012C (en) 2012-05-08 2017-06-20 Aeromics, Llc New methods
RU2691951C2 (ru) 2013-11-06 2019-06-19 Аэромикс, Инк. Новые составы
CN110054647B (zh) * 2019-05-23 2021-06-15 上海勋和医药科技有限公司 托拉塞米磷酸酯类前药、其制备方法及组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8809205D0 (en) * 1988-04-19 1988-05-25 Nye P C G Treatment of oedema

Also Published As

Publication number Publication date
CA2108794C (en) 2003-06-24
WO1992019245A1 (de) 1992-11-12
AU1669092A (en) 1992-12-21
EP0583280B1 (de) 1996-08-07
DE4113820A1 (de) 1992-10-29
JPH06506677A (ja) 1994-07-28
ATE141053T1 (de) 1996-08-15
EP0583280A1 (de) 1994-02-23
JP3429507B2 (ja) 2003-07-22
DE59206872D1 (de) 1996-09-12
CA2108794A1 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
EA199700437A1 (ru) Микроинкапсулированные лактобациллы для медицинского применения
CA2100212A1 (en) Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
HUP9900508A2 (hu) 2-Amino-4-(4-fluor-benzil-amino)-1-(etoxi-karbonil-amino)-benzol alkalmazása agyi vérellátási zavarok, valamint neurodegeneratív megbetegedések következményeinek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
ES2082887T3 (es) Flupirtina en combinacion con antiparkinsonianos para combatir espasmos musculares.
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
GR3007393T3 (es)
ES2093257T3 (es) Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales.
BR9407293A (pt) Efeitos neutoprotetores primários e secundários do flupirtino nas doenças neurodegenerativas
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
NO873108D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
NO951995L (no) Kombinasjon av atovaquon med proguantil for behandling av protozoinfeksjoner
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ITMI910381A0 (it) Medicamento per il trattamento della dermatite
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
EP0147707A3 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
NO874241D0 (no) Terapeutisk aktive salter.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
PT89582B (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 583280

Country of ref document: ES